UBS Group AG - OMEGA THERAPEUTICS INC ownership

OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 45 filers reported holding OMEGA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of OMEGA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28,210
-66.5%
13,121
-12.8%
0.00%
Q2 2023$84,224
+244.5%
15,040
+271.0%
0.00%
Q1 2023$24,445
+160.4%
4,054
+146.6%
0.00%
Q4 2022$9,387
-53.1%
1,644
-54.4%
0.00%
Q3 2022$20,000
+900.0%
3,604
+1113.5%
0.00%
Q1 2022$2,000
-90.0%
297
-83.0%
0.00%
Q4 2021$20,000
+5.3%
1,752
+78.0%
0.00%
Q3 2021$19,0009840.00%
Other shareholders
OMEGA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 352,941$6,653,0008.31%
CHI Advisors LLC 1,055,882$19,904,0005.81%
Flagship Pioneering Inc. 25,902,269$488,258,0005.11%
HARBOURVEST PARTNERS LLC 2,647,059$49,897,0004.69%
Octagon Capital Advisors LP 370,279$6,980,0001.72%
Monashee Investment Management LLC 441,176$8,316,0001.54%
Artal Group S.A. 2,273,530$42,856,0000.96%
SPHERA FUNDS MANAGEMENT LTD. 527,948$9,952,0000.84%
PLATINUM INVESTMENT MANAGEMENT LTD 500,000$9,425,0000.26%
Logos Global Management LP 88,235$1,663,0000.12%
View complete list of OMEGA THERAPEUTICS INC shareholders